Aplio i900 vs Tempus ECG-AF
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A, Aplio i900, is a premium cardiovascular ultrasound system that uses AI for advanced imaging and real-time diagnostic analysis of cardiac structures and function. Tool B, Tempus ECG-AF, is an AI-based software algorithm designed to analyze 12-lead ECGs for predicting the risk of new-onset atrial fibrillation in specific patient populations. While both leverage AI in cardiology, they address different clinical needs: one for advanced imaging diagnostics and the other for predictive risk stratification based on ECG data.
Choose Aplio i900 if…
Choose the Aplio i900 if your cardiology department requires a premium, high-resolution ultrasound system for comprehensive and precise real-time cardiovascular diagnostics. This tool is ideal for advanced structural and functional assessments, including complex 4D imaging and detailed quantitative analysis, to guide treatment decisions for a wide range of cardiac conditions.
View Aplio i900 →Choose Tempus ECG-AF if…
Choose Tempus ECG-AF if your practice aims to proactively identify older patients at increased risk of developing new-onset atrial fibrillation within the next year. This AI-powered software solution is best suited for screening patients aged 65 or older without a prior AF diagnosis, enabling earlier intervention and focused follow-up to potentially improve patient outcomes.
View Tempus ECG-AF →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Aplio i900 | Tempus ECG-AF |
|---|---|---|
| Pricing | Varies | Contact vendor |
| Deployment | Mobile, compact diagnostic ultrasound system | Software solution, integrated into healthcare facility systems with advanced cardiology algorithms. |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Yes AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Aplio i900 | Tempus ECG-AF |
|---|---|---|
| Name | Aplio i900 | Tempus ECG-AF |
| Company | Canon Medical Systems Corporation | Tempus AI, Inc. |
| Description | The Aplio i900 is a premium cardiovascular diagnostic ultrasound system by Canon Medical Systems, featuring advanced 4D imaging, AI-powered image enhancement, and automated analysis tools for precise and efficient cardiac diagnostics. | Tempus ECG-AF is an FDA-cleared AI-based algorithm that analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months, supporting earlier identification and follow-up. |
| Categories | Cardiology AI, Radiology & Imaging AI | Cardiology AI |
| Key Features | Premium Cardiovascular Ultrasound System, Advanced 4D Imaging (e.g., 4D TEE, MVA), Automated Analysis & Measurement Tools (EF, GLS, MPI, 3D Wall Motion Tracking), iPerformance (Extreme Processing Power), iSense & Touch-control Screens for Intuitive Ergonomics, Real-time Quick Scan for Automatic Image Adjustments, 3rd Harmonic Imaging (3-HI) with Deep Learning AI, SMI Angio (Superb Micro-vascular Imaging) for Microvascular Flow | AI-based algorithm for 12-lead ECG analysis, Detects signs associated with new onset Atrial Fibrillation (AF) within 12 months, Intended for patients 65 years or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery, Results interpreted in conjunction with other diagnostic information and clinical history, Compatible with FDA authorized resting 12-lead ECGs from GE Medical Systems and Philips Medical Systems, Trained on over 1.5 million ECGs from over 500,000 patients |
Videos
Demos, reviews, and walkthroughs featuring Aplio i900 and Tempus ECG-AF.
Loading videos…
Videos need JavaScript to load. Search YouTube directly →
Frequently Asked Questions
The Aplio i900 is a premium cardiovascular diagnostic ultrasound system designed for advanced 4D imaging and automated analysis across various cardiac conditions. Tempus ECG-AF is an AI-based algorithm that analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months.
The Aplio i900 is a general cardiovascular diagnostic tool, suitable for a wide range of applications including adult, pediatric, fetal echo, and stress echo. Tempus ECG-AF is specifically intended for patients aged 65 or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery.
For Tempus ECG-AF, CMS reimbursement is available with CPT codes 0764T and 0765T to APC 5734, with a Medicare rate of $128.90, effective January 1, 2025. Pricing for the Aplio i900 is not publicly available and requires contacting the vendor.
The Aplio i900 features AI-powered image enhancement, automated analysis tools for measurements like Ejection Fraction (EF), Global Longitudinal Strain (GLS), and Myocardial Performance Index (MPI), and 3rd Harmonic Imaging with Deep Learning AI. Tempus ECG-AF is an AI-based algorithm specifically for analyzing 12-lead ECG recordings to identify risk of new onset Atrial Fibrillation.